Will Stone

Only about 7% of commenters opposed rescheduling, according to the study published in the medical journal Addiction.

The Trump administration has already rescheduled medical marijuana, and it will be holding a hearing over the summer to discuss whether that should apply to all cannabis, not just for medical purposes.

Will Stone, NPR News.

Researchers at Harvard Medical School found that an AI reasoning model developed by OpenAI excelled at diagnosing patients and making decisions about managing their care.

It matched and often outperformed doctors in the earlier AI model, GPT-4.

The study included actual cases from the emergency department at Beth Israel Deaconess Medical Center.

Dr. Adam Rodman was one of the study authors.

Rodman says their study does not suggest AI should replace doctors, but it is a call to do forward-looking trials to see whether AI models can actually improve care.

Will Stone, NPR News.

Three companies are submitting drug applications to the FDA.

Two are for psilocybin, the active ingredient in magic mushrooms for treating depression.

The third is for a drug that's similar to MDMA, which has shown promise for PTSD.

FDA is giving out special vouchers that are intended to expedite the agency's review of the drugs.

It does not mean the drugs are FDA approved yet.

This comes on the heels of an executive order from President Trump that directs federal health agencies to prioritize research on psychedelics.

Scientific interest in these drugs for treating mental health has grown substantially in the last few years, though an effort to get MDMA approved for treating PTSD fell short in 2024.

Will Stone, NPR News.

Three companies are submitting drug applications to the FDA.

Two are for psilocybin, the active ingredient in magic mushrooms for treating depression.

The third is for a drug that's similar to MDMA, which has shown promise for PTSD.